Emergent BioSolutions Partners with U.S. Government for Comprehensive Response to Expedite Development of Plasma-Derived Therapy for COVID-19

NEXT STORY
Dynavax Provides Business Update on COVID-19 Pandemic Impact
PREV STORY
electroCore Submits Emergency Use Authorization Application to Allow the Study and Use of gammaCore nVNS Therapy to Treat Respiratory Symptoms Associated with COVID-19
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Verona Pharma Reports Financial Results for the Full Year Ended December 31, 2019 and Provides Corporate Update

author_avatar
NASDAQ Market News

Medical Waste Management Market To Reach USD 17.89 Billion by 2026 | Reports And Data

author_avatar
NASDAQ Market News

Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

WALTHAM, Mass., July 16, 2018 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the ...

author_avatar
NASDAQ Market News